María Teresa P. R.
- Country
- Spain
- Department
- Servicio de Medicina Interna. Unidad de Enfermedades Infecciosas
Research Overview
- Evaluation of Treatment Strategies for Severe Gram-Negative Bacterial Infections Using Antimicrobial Agents and Drug Combinations
- Phase 3 Evaluation of ExPEC9V Vaccine for Preventing Invasive Extraintestinal Pathogenic Escherichia coli Disease in Adults Aged 60+ with Prior Urinary Tract Infection
- Comparative Efficacy of Temocillin Sodium Versus Meropenem and Ertapenem Sodium in Treating Enterobacteriaceae Bacteremia Resistant to Third-Generation Cephalosporins
Data & Insights
Has run more than one trial at 39 of 208 partner sites.
Specializations
Infectious Diseases and Antimicrobial Therapy
Clinical activity includes management of HIV, COVID-19, nontuberculous mycobacterial lung infection, bacterial bacteraemia, and prevention of invasive pneumococcal and ExPEC disease, with interest in treatment strategies for resistant Enterobacterales and Gram-negative infections.
- HIV infection and pre-exposure prophylaxis
- Mycobacterial lung disease
- Severe bacterial infections and bacteraemia
- Vaccine-preventable respiratory infection
The therapeutic focus extends to infection prevention, antimicrobial selection, and control of complicated respiratory and bloodstream infections.
Cardiovascular Medicine and Vascular Risk Reduction
Research involvement covers acute myocardial infarction, acute coronary syndrome, coronary artery disease, stroke prevention, heart failure, atrial fibrillation, aortic stenosis, and broader atherosclerotic cardiovascular disease.
- Myocardial infarction and ischemic stroke
- Coronary intervention and antiplatelet therapy
- Heart failure and cardiomyopathy
- Structural heart disease
Therapeutic interest also includes secondary prevention, lipid lowering, thrombotic risk reduction, and post-procedural cardiovascular care.
Oncology and Hematologic Malignancies
Clinical research spans breast cancer, ovarian cancer, non-small cell lung cancer, small-cell lung cancer, colorectal cancer, renal cell carcinoma, prostate cancer, and lymphoid malignancies.
- HER2-positive and hormone receptor-positive breast cancer
- Ovarian and endometrial cancer
- Lung cancer and thoracic oncology
- Lymphoma and myeloma
The therapeutic landscape includes targeted treatment, immunotherapy, and perioperative cancer management across solid and hematologic tumors.
Autoimmune, Inflammatory, and Neurological Disorders
Areas of interest include systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, Sjögren’s syndrome, systemic sclerosis, Crohn’s disease, ulcerative colitis, multiple sclerosis, autoimmune encephalitis, epilepsy, and migraine.
- Systemic autoimmune rheumatic diseases
- Inflammatory bowel disease
- Demyelinating disease
- Seizure disorders and headache disorders
Therapeutic interest also extends to neuroimmunology, symptom control, relapse prevention, and long-term disease suppression.
Psychiatry, Metabolic Disease, and Pulmonary Medicine
Additional clinical involvement includes major depressive disorder, obsessive compulsive disorder, schizophrenia, type 2 diabetes, idiopathic pulmonary fibrosis, and interstitial lung disease.
- Depressive disorders and compulsive disorders
- Psychotic disorders
- Diabetes and metabolic risk
- Fibrotic lung disease
This work reflects therapeutic attention to chronic neuropsychiatric disease, metabolic comorbidity, and progressive respiratory conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.